Shaw's update says management continues to see improving outlook for hospital IT spend and growth in sales funnel.
"Positive 3Q22 cashflow drives record closing cash balance–M7T reported 3Q22 cash
receipts of $6.4m and total cash costs of-$6.0m (vs $5.7m in 2Q), implying gross free
cash flowofpositive$0.5m.FY22 YTDM7T has delivered gross free cashflow of $1.4m,
which well ahead of previous years (FY20 $0.8m and FY21 $0.2m). With a largely scaled
cost base and improving outlook for sales orders, we believe M7T has now sustainably
transitioned to a positive cashflow company (on a rolling 12mth basis).M7T closed 3Q22
with a record cash balance of $20.6m, putting it in a strong capital position."
Shaw's update says management continues to see improving outlook...
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add M7T (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
64.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $154.3M | |||
| Open | High | Low | Value | Volume |
| 62.5¢ | 64.5¢ | 62.0¢ | $92.90K | 147.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 19484 | 63.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 64.5¢ | 21843 | 1 |
View Market Depth
| Last trade - 15.50pm 28/06/2024 (20 minute delay) ? |
| M7T (ASX) Chart |